AMAG Pharmaceuticals, Inc. (AMAG) News
Filter AMAG News Items
AMAG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest AMAG News From Around the Web
Below are the latest news stories about Amag Pharmaceuticals Inc that investors may wish to consider to help them evaluate AMAG as an investment opportunity.
Covis takes out Amag Pharma for $498MApollo Global Management portfolio company Covis Group S.à r.l. has agreed to acquire AMAG Pharmaceuticals ([[AMAG]] +43.9%) for $13.75 per share in cash. The total transaction value is ~$498M on a fully diluted basis or ~$647M on an enterprise basis including debt.The tender offer for AMAG shares will commence this... |
AMAG Pharma up 41% on takeover rumorAMAG Pharmaceuticals (AMAG) jumps 41% after hours in apparent response to rumors that Apollo Global (APO) portfolio company Covis Pharma is about to acquire the company.Covis is a Netherlands-based specialty pharmaceutical company that only months ago was purchased by Apollo for an undisclosed sum.It's been a rough few years for AMAG, which... |
AMAG, ODT, SPI and NG among after-hours moversGainers: [[AMAG]] +39.4%. [[DNOW]] +9.9%. [[DTIL]] +5.5% [[MNOV]] +5.0%. [[ODT]] +4.5%.Losers: [[LOGC]] -25.1%. [[SPI]] -15.6%. [[AMBO]] -5.9%. [[NG]] -5.9%. [[CC]] -4.3%.... |
AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseAMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New ZealandAgreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties Collaboration further advances the development of ciraparantagWALTHAM, Mass. and AMSTERDAM, The Netherlands, July 23, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Norgine B.V., a leading European specialist pharmaceutical company, today announced they have entered into an exclusive licensing agreement to develop and commercialize ciraparantag in Europe, Australia and New Zealand. Ciraparantag is in development for use in patients treated with direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) when reversal of the anticoagulant effect of these products is needed f... |
When Will AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Breakeven?AMAG Pharmaceuticals, Inc.'s (NASDAQ:AMAG): AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops... |
AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and HaemostasisWALTHAM, Mass., July 12, 2020 -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the poster presentation of data from two Phase 2 randomized, placebo-controlled, dose. |
Forensic Value Stock Analysis: Top Positive And Negative Scoring Stocks Mid-Year 2020Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study compiles portfolio selections from the highest positive and highest negative scoring stocks... |
Hedge Funds Still Kind Of Bullish On AMAG Pharmaceuticals, Inc. (AMAG)How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] |
AMAG Pharma's finance chief bids adieuAMAG Pharmaceuticals' (AMAG) Chief Financial Officer ((CFO)) and Chief Operating Officer ((COO)), Edward (Ted) Myles is leaving the Company.Brian Piekos, Senior Vice President of Finance, has been appointed interim CFO. He joined AMAG in 2015.Anthony (Tony) Casciano has been appointed COO. He joined AMAG in September 2016.Prior to AMAG, Mr. Casciano spent 16 years at... |